Skip to main content
. 2017 Aug 9;4(5):e390. doi: 10.1212/NXI.0000000000000390

Figure 2. BVL according to on-study disability worsening.

Figure 2

BVL according to on-study disability worsening in (A) placebo-treated patients with and without 12- or 24-week confirmed disability worsening (CDW); (B) placebo- and teriflunomide 14 mg–treated patients with 12- or 24-week CDW; (C) placebo- and teriflunomide 14 mg–treated patients without 12- or 24-week CDW. BVL = brain volume loss; CI = confidence interval. *Relative change vs patients without CDW; **Relative change vs placebo.